NO20032340D0 - Substituerte derivater av aminofuran-2-yl-eddiksyre og aminotien-2-yl-eddiksyre og deres anvendelse for behandling av migrene og smerte - Google Patents
Substituerte derivater av aminofuran-2-yl-eddiksyre og aminotien-2-yl-eddiksyre og deres anvendelse for behandling av migrene og smerteInfo
- Publication number
- NO20032340D0 NO20032340D0 NO20032340A NO20032340A NO20032340D0 NO 20032340 D0 NO20032340 D0 NO 20032340D0 NO 20032340 A NO20032340 A NO 20032340A NO 20032340 A NO20032340 A NO 20032340A NO 20032340 D0 NO20032340 D0 NO 20032340D0
- Authority
- NO
- Norway
- Prior art keywords
- acetic acid
- aminothien
- aminofuran
- migraine
- pain
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10059864A DE10059864A1 (de) | 2000-11-30 | 2000-11-30 | Substituierte Amino-furan-2-yl-essigsäure- und Amino-thien-2-yl-essigsäure-Derivate |
| PCT/EP2001/013910 WO2002044171A1 (de) | 2000-11-30 | 2001-11-28 | Substituierte amino-furan-2-yl-essigsaure- und amino-thien-2-yl-essigsaure-derivate und ihre verwendung zur behandlung von migraine bzw. schmerz |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20032340D0 true NO20032340D0 (no) | 2003-05-23 |
| NO20032340L NO20032340L (no) | 2003-07-21 |
Family
ID=7665508
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20032340A NO20032340L (no) | 2000-11-30 | 2003-05-23 | Substituerte aminofuran-2-yl-eddiksyre- og aminotien-2-yl- eddiksyrederivater og deres anvendelse for behandling av migrene og henholdsvissmerte |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US6797712B2 (no) |
| EP (1) | EP1341786B9 (no) |
| JP (1) | JP4340063B2 (no) |
| KR (1) | KR20030055334A (no) |
| CN (1) | CN1326854C (no) |
| AR (1) | AR035658A1 (no) |
| AT (1) | ATE418552T1 (no) |
| AU (2) | AU2073502A (no) |
| BR (1) | BR0115883A (no) |
| CA (1) | CA2430280A1 (no) |
| CY (1) | CY1108871T1 (no) |
| CZ (1) | CZ20031509A3 (no) |
| DE (2) | DE10059864A1 (no) |
| DK (1) | DK1341786T3 (no) |
| EC (1) | ECSDI034631S (no) |
| ES (1) | ES2320198T3 (no) |
| HK (1) | HK1059080A1 (no) |
| HU (1) | HUP0303041A3 (no) |
| IL (2) | IL156139A0 (no) |
| MX (1) | MXPA03004303A (no) |
| NO (1) | NO20032340L (no) |
| NZ (1) | NZ526554A (no) |
| PE (1) | PE20020599A1 (no) |
| PL (1) | PL362978A1 (no) |
| PT (1) | PT1341786E (no) |
| RU (1) | RU2003117703A (no) |
| SI (1) | SI1341786T1 (no) |
| SK (1) | SK5942003A3 (no) |
| WO (1) | WO2002044171A1 (no) |
| ZA (1) | ZA200305009B (no) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6794506B2 (en) * | 2000-07-21 | 2004-09-21 | Elan Pharmaceuticals, Inc. | 3-(heteroaryl) alanine derivatives-inhibitors of leukocyte adhesion mediated by VLA-4 |
| DE10125145A1 (de) * | 2001-05-22 | 2002-11-28 | Gruenenthal Gmbh | Substituierte C-Furan-2-yl-methylamin- und C-Thiophen-2-yl-methylamin-Derivate |
| GB0302094D0 (en) * | 2003-01-29 | 2003-02-26 | Pharmagene Lab Ltd | EP4 receptor antagonists |
| DE10306203A1 (de) * | 2003-02-13 | 2004-08-26 | Grünenthal GmbH | Arzneimittel enthaltend substituierte 2-Heteroaryl-Aminoessigsäure-Verbindungen |
| DE10306202A1 (de) * | 2003-02-13 | 2004-08-26 | Grünenthal GmbH | Arzneimittel enthaltend substituierte 2-Aryl-Aminoessigsäure-Verbindungen und/oder substituierte 2-Heteroaryl-Aminoessigsäure-Verbindungen |
| GB0324269D0 (en) | 2003-10-16 | 2003-11-19 | Pharmagene Lab Ltd | EP4 receptor antagonists |
| WO2008009078A2 (en) | 2006-07-20 | 2008-01-24 | Gilead Sciences, Inc. | 4,6-dl- and 2,4,6-trisubstituted quinazoline derivatives useful for treating viral infections |
| US10144736B2 (en) * | 2006-07-20 | 2018-12-04 | Gilead Sciences, Inc. | Substituted pteridines useful for the treatment and prevention of viral infections |
| CA2978188C (en) | 2015-03-04 | 2020-05-12 | Gilead Sciences, Inc. | Toll-like receptor modulating 4,6-diamino-pyrido[3,2-d]pyrimidine compounds |
| US10640499B2 (en) | 2016-09-02 | 2020-05-05 | Gilead Sciences, Inc. | Toll like receptor modulator compounds |
| WO2018045144A1 (en) | 2016-09-02 | 2018-03-08 | Gilead Sciences, Inc. | Toll like receptor modulator compounds |
| TW202210480A (zh) | 2019-04-17 | 2022-03-16 | 美商基利科學股份有限公司 | 類鐸受體調節劑之固體形式 |
| TW202212339A (zh) | 2019-04-17 | 2022-04-01 | 美商基利科學股份有限公司 | 類鐸受體調節劑之固體形式 |
| TW202115056A (zh) | 2019-06-28 | 2021-04-16 | 美商基利科學股份有限公司 | 類鐸受體調節劑化合物的製備方法 |
| CN115382297B (zh) * | 2022-04-12 | 2023-10-31 | 江阴市华思诚无纺布有限公司 | 熔体直纺双组分pet纺粘液体过滤材料及其制备方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998000398A1 (en) * | 1996-06-28 | 1998-01-08 | University Of Southern California | Method for the synthesis of amines and amino acids with organoboron derivatives |
| US6441237B1 (en) | 1999-02-20 | 2002-08-27 | Boehringer Ingelheim Pharma Kg | Substituted 3-phenoxy- and 3-phenylalkyloxy-2-phenyl-propylamines |
| DE19907385A1 (de) * | 1999-02-20 | 2000-08-24 | Boehringer Ingelheim Pharma | Neue substituierte 3-Phenoxy- und 3-Phenylalkyloxy-2-phenyl-propylamine |
| GB0030304D0 (en) * | 2000-12-13 | 2001-01-24 | Lilly Co Eli | Compounds |
-
2000
- 2000-11-30 DE DE10059864A patent/DE10059864A1/de not_active Ceased
-
2001
- 2001-11-26 AR ARP010105486A patent/AR035658A1/es not_active Application Discontinuation
- 2001-11-28 IL IL15613901A patent/IL156139A0/xx active IP Right Grant
- 2001-11-28 MX MXPA03004303A patent/MXPA03004303A/es active IP Right Grant
- 2001-11-28 HU HU0303041A patent/HUP0303041A3/hu unknown
- 2001-11-28 CZ CZ20031509A patent/CZ20031509A3/cs unknown
- 2001-11-28 JP JP2002546541A patent/JP4340063B2/ja not_active Expired - Fee Related
- 2001-11-28 EP EP01998547A patent/EP1341786B9/de not_active Expired - Lifetime
- 2001-11-28 SK SK594-2003A patent/SK5942003A3/sk not_active Application Discontinuation
- 2001-11-28 PL PL01362978A patent/PL362978A1/xx not_active Application Discontinuation
- 2001-11-28 DK DK01998547T patent/DK1341786T3/da active
- 2001-11-28 AT AT01998547T patent/ATE418552T1/de active
- 2001-11-28 CN CNB018197876A patent/CN1326854C/zh not_active Expired - Fee Related
- 2001-11-28 AU AU2073502A patent/AU2073502A/xx active Pending
- 2001-11-28 ES ES01998547T patent/ES2320198T3/es not_active Expired - Lifetime
- 2001-11-28 RU RU2003117703/04A patent/RU2003117703A/ru not_active Application Discontinuation
- 2001-11-28 NZ NZ526554A patent/NZ526554A/en unknown
- 2001-11-28 WO PCT/EP2001/013910 patent/WO2002044171A1/de active IP Right Grant
- 2001-11-28 DE DE50114605T patent/DE50114605D1/de not_active Expired - Lifetime
- 2001-11-28 SI SI200130905T patent/SI1341786T1/sl unknown
- 2001-11-28 BR BR0115883-0A patent/BR0115883A/pt not_active IP Right Cessation
- 2001-11-28 KR KR10-2003-7007315A patent/KR20030055334A/ko not_active Application Discontinuation
- 2001-11-28 AU AU2002220735A patent/AU2002220735B2/en not_active Ceased
- 2001-11-28 CA CA002430280A patent/CA2430280A1/en not_active Abandoned
- 2001-11-28 PT PT01998547T patent/PT1341786E/pt unknown
- 2001-11-29 PE PE2001001195A patent/PE20020599A1/es not_active Application Discontinuation
-
2003
- 2003-05-23 NO NO20032340A patent/NO20032340L/no not_active Application Discontinuation
- 2003-05-27 IL IL156139A patent/IL156139A/en not_active IP Right Cessation
- 2003-05-29 EC EC2003004631F patent/ECSDI034631S/es unknown
- 2003-05-30 US US10/448,323 patent/US6797712B2/en not_active Expired - Fee Related
- 2003-06-26 ZA ZA200305009A patent/ZA200305009B/en unknown
-
2004
- 2004-03-09 HK HK04101704.1A patent/HK1059080A1/xx not_active IP Right Cessation
-
2009
- 2009-03-12 CY CY20091100279T patent/CY1108871T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20032695L (no) | Karboksamidderivater og deres anvendelse ved behandling av tromboemboliskesykdommer | |
| NO20023566D0 (no) | Propionsyrederivater og deres anvendelse ved behandling av sukkkersyke og fedme | |
| NO20023043L (no) | Substituerte oksazolidinoner og deres anvendelse innenfor feltet blodkoagulasjon | |
| NO20016149D0 (no) | Indol-derivater og deres anvendelse for behandling av osteporose blant andre applikasjoner | |
| NO20014858L (no) | Anvendelse av CYP2D6 inhibitorer i kombinasjonsterapi | |
| NO20005387D0 (no) | 3-(amino- eller aminoalkyl-)pyridinonderivater og deres anvendelse for behandling av HIV-relaterte sykdommer | |
| NO20032340L (no) | Substituerte aminofuran-2-yl-eddiksyre- og aminotien-2-yl- eddiksyrederivater og deres anvendelse for behandling av migrene og henholdsvissmerte | |
| NO20022680L (no) | Farmasoytiske kombinasjoner og deres anvendelse ved behandling av gastrointestinale forstyrrelser | |
| NO20043370L (no) | N-pyrazinylfenylsulfonamider og deres anvendelse ved behandling av kemokinmedierte sykdommer | |
| NO20052699D0 (no) | 4(fenylpiperazinyl-metyl)benzamid-derivater og deres anvendelse ved behandling av smerte og gastrointestinale lidelser. | |
| EE200200571A (et) | Hüdroksüfenüülpiperidiin-4-ülideenmetüülbensamiidi derivaadid valu raviks | |
| NO20041214L (no) | Substituerte benzimidazolforbindelser og deres anvendelse for behandling av cancer | |
| IS6966A (is) | Cýanó-tengd díhýdrópýrimídín efnasambönd og notkun þeirra við meðhöndlun sjúkdóma | |
| NO20034300D0 (no) | Nye cyano-substituerte dihydropyrimidinforbindelser og anvendelse for behandling av sykdommer | |
| NO20030295D0 (no) | Anvendelse av derivater av valproinsyre- og 2- valproensyreamider for behandling av manier ved bipolare lidelser | |
| AU2002220735A1 (en) | Substituted derivatives of aminofuran-2-yl-acetic acid and aminothien-2-yl-acetic acid and the use thereof for treating migraines and pain | |
| NO20020031D0 (no) | Dihydrobenzodiazepiner og deres anvendelse ved behandling av dyslipidemi | |
| EE200200511A (et) | Hüdroksüfenüülpiperasinüülmetüülbensamiidi derivaadid valu raviks | |
| EE200200577A (et) | Kinolinüülpiperidiin-4-ülideenmetüülbensamiidi derivaadid valu raviks | |
| NO994426D0 (no) | Nye karboksylsyrederivater, deres fremstilling og anvendelse ved behandling av kreft | |
| NO20043029L (no) | Karboksamidinderivater og deres anvendelse ved behandling av vaskulaere sykdommer | |
| NO20030547L (no) | Azabicykliske derivater og deres terapeutiske anvendelse | |
| NO985974D0 (no) | Piperidineddiksyrederivater og deres anvendelse ved behandling av trombose-sykdommer | |
| NO20022990L (no) | Fremgangsmåte og sammensetning for behandling av smerte | |
| AU2001254825A1 (en) | Butenoic acids derivatives and their use in the treatment of rhinitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |